Kristin Higgins, MD
Radiation Oncology · Atlanta, GANPI 1730353327
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $201,039 of the $230,086 with a category attached, or 87.4%. AstraZeneca accounts for 69.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $76,221 and has fallen 62.8% since, to $28,375 in 2025. Among radiation oncology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $1620.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$159K
- Astrazeneca UK Limited$39K
- Daiichi Sankyo Inc.$20K
- Janssen Scientific Affairs, LLC$6K
- Regeneron$2K
- Reflexion Medical, Inc.$1K
- plus $2K from 8 others
Across 22 payments — averaging $261,984 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$5.3M
- Jazz Pharmaceuticals Inc.$377K
- AstraZeneca$131K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$201,03987%
- Speaking & faculty fees$1,0000%
- Travel & lodging$23,81710%
- Food & beverage$4,0282%
- Education$240%
- Gifts$1780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 84 | $159,133 |
| Astrazeneca UK Limited | 20 | $38,742 |
| Daiichi Sankyo Inc. | 6 | $20,122 |
| Janssen Scientific Affairs, LLC | 3 | $5,860 |
| Regeneron | 3 | $2,458 |
| Reflexion Medical, Inc. | 7 | $1,486 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,000 |
| Genentech, Inc. | 5 | $398 |
| Genentech USA, Inc. | 4 | $288 |
| Varian Medical Systems, Inc. | 2 | $232 |
| Novocure Inc. | 3 | $182 |
| Pfizer | 2 | $151 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$230,086 in reported general payments places this provider in the 95th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Atlanta
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
- Ashesh JaniAtlanta$10K
- Frederick SchnellAtlanta$6K
- Mohammad KhanAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.